Aurinia Pharmaceuticals (AUPH) Ownership - Who Owns Aurinia Pharmaceuticals?

Compare

2,109 Followers

Aurinia Pharmaceuticals (AUPH) Ownership Overview

11.26% Insiders

4.15% Mutual Funds

17.84% Other Institutional Investors

6.94% ETFs

59.81% Public Companies and

Individual Investors

The ownership structure of Aurinia Pharmaceuticals (AUPH) stock is a mix of institutional, retail, and individual investors. Approximately 28.94% of the company’s stock is owned by Institutional Investors, 11.26% is owned by Insiders, and 59.81% is owned by Public Companies and Individual Investors.

The ownership structure of Aurinia Pharmaceuticals (AUPH) stock is a mix of institutional, retail, and individual investors. Approximately 21.99% of the company’s stock is owned by Institutional Investors, 11.26% is owned by Insiders, and 6.94% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date	Name	Activity	Value
Aug 05, 2025	Greg Keenan	xxxxxxxxxxxxx	$210000
Aug 05, 2025	Kevin Tang	xxxxxxxxxxxxx	$13590000

Show More Insider Trading Activity >

Top Shareholders

# of Shares	Type	% Holding	Value
11,329,500	Insider	8.52%	162,125,145
5,312,595	Institution	4.00%	76,023,234
1,744,866	Insider	1.31%	24,969,032
1,515,343	Institution	1.14%	21,684,558
1,257,214	Institution	0.95%	17,990,732
1,232,887	Institution	0.93%	17,642,613
704,132	Institution	0.53%	10,076,129
681,813	Institution	0.51%	9,756,744
662,900	Insider	0.50%	9,486,099
556,703	Insider	0.42%	7,966,420

Top Mutual Fund Holders

# of Shares	Type	% Holding	Value
1,515,343	Institution	1.14%	21,684,558
1,257,214	Institution	0.95%	17,990,732
681,813	Institution	0.51%	9,756,744
441,012	Institution	0.33%	6,310,882
339,164	Institution	0.26%	4,853,437
111,924	Institution	0.08%	1,601,632
105,000	Institution	0.08%	1,502,550
96,907	Institution	0.07%	1,386,739
96,715	Institution	0.07%	1,383,992
92,212	Institution	0.07%	1,319,554

Top ETF Holders

Holder	# of Shares	Type	% Holding	Value
iShares Russell 2000 ETF	2,840,575	Institution	2.14%	39,626,021
iShares Russell 2000 Growth ETF	1,003,583	Institution	0.75%	13,999,983
iShares Biotechnology ETF	854,760	Institution	0.64%	11,923,902
Vanguard Russell 2000 ETF	568,301	Institution	0.43%	8,257,414
Janus Henderson Small/Mid Cap Growth Alpha ETF	512,592	Institution	0.39%	7,150,658
Vanguard Health Care ETF	338,568	Institution	0.25%	4,919,393
Fidelity Enhanced Small Cap ETF	253,353	Institution	0.19%	3,640,683
Avantis U.S Small Cap Equity ETF	241,539	Institution	0.18%	3,470,915
Janus Henderson Small Cap Growth Alpha ETF	191,540	Institution	0.14%	2,671,983
Principal U.S. Small-Cap Multi-Factor ETF	114,774	Institution	0.09%	1,649,302

FAQ

Who Owns Aurinia Pharmaceuticals (AUPH)?

According to the latest TipRanks data, approximately 17.84% of the company's stock is held by institutional investors, 11.26% is held by insiders, and 59.81% is held by retail investors.

What percentage of Aurinia Pharmaceuticals (AUPH) stock is held by institutional investors?

According to the latest TipRanks data, approximately 17.84% of Aurinia Pharmaceuticals (AUPH) stock is held by institutional investors.

What percentage of Aurinia Pharmaceuticals (AUPH) stock is held by retail investors?

According to the latest TipRanks data, approximately 59.81% of Aurinia Pharmaceuticals (AUPH) stock is held by retail investors.

Who owns the most shares of Aurinia Pharmaceuticals (AUPH)?

Kevin Tang owns the most shares of Aurinia Pharmaceuticals (AUPH).

What is the significance of the ownership structure for a publicly traded company?

The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.